Home | For Faculty | Help | About | Webmaster

Deborah L. Goodman - Gruen

Associate Professor, Epidemiology
School of Medicine

M.D., Rosalind Franklin University / The Chicago Medical School, 1987


Ph.D., University of California, Los Angeles, 1993, Epidemiology


M.P.H., University of California, Los Angeles, 1983, Epidemiology

Phone: (949) 824-7401
Fax: (949) 824-4773
Email: goodmand@uci.edu

University of California, Irvine
224 Irvine Hall
University of California
Mail Code: 7550
Irvine, CA 92697


Research
Interests
Cancer Epidemiology, Chronic Disease Prevention
   
URLs Department of Epidemiology
   
Genetic Epidemiology Research Institute (GERI)
   
Academic
Distinctions
Physician Scientist Award, University of California, San Diego 1993-1995

National Research Service Award 1990-1993


MEDICAL QUALIFICATIONS:

Preventive Medicine Board Certification, 1993

Licensure, California, 1989 (#G65438)
   
Appointments Resident, University of California, Los Angeles, Department of Preventive Medicine 1989-1992

Resident, University of California, Los Angeles, Department of Obstetrics and Gynecology 1987-1989
   
Publications Listing:

Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-515.

Goodman-Gruen DL. The Relationship Between Body Composition and Age at Menarche Among Adolescent Girls. Ph.D. dissertation. University of California, Los Angeles, 1993.

Goodman-Gruen DL, Barrett-Connor EL. A 19-year prospective study of dehydroepiandrosterone sulfate and cardiovascular disease mortality in postmenopausal women: The Rancho Bernardo Study. Clinical Research (Abstract) 1994;42:62A.

Barrett-Connor E, Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women: The Rancho Bernardo Study. Circulation 1995;91:1757-1760.

Goodman-Gruen DL, Barrett-Connor EL. Total but not bioavailable testosterone is a predictor of central adiposity in postmenopausal women. Int J Obesity 1995;19:293-298.

Barrett-Connor E, Goodman-Gruen D. A prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. Clinical Research (Abstract) 1995;43.

Barrett-Connor E, Goodman-Gruen D. A prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 1995;311:1193-1196.

Barrett-Connor E, Goodman-Gruen D. The Epidemiology of DHEAS and cardiovascular disease. Ann New York Academy of Sciences 1996;774:259-70.

Goodman-Gruen D, Barrett-Connor E. Sex differences in measures of body fat and body fat distribution in the elderly. Am J Epidemiol 1996;143:898-906.

Goodman-Gruen D, Barrett-Connor E. A prospective study of sex hormone binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women. Clinical Research (Abstract) 1996.

Goodman-Gruen D, Barrett-Connor E. A prospective study of sex hormone binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women. J Clin Endocrinol Metab 1996;81:2999-3003.

Goodman-Gruen D, Barrett-Connor E. The effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: The Rancho Bernardo Study. J Clin Endocrinol Metab 1996;81:4268-4271.

Gabal L, Goodman-Gruen D, Barrett-Connor E. A prospective study of the effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus. Am J Public Health 1997;87:443-5.

Goodman-Gruen D, Barrett-Connor E. Sex hormone binding globulin and glucose tolerance in postmenopausal women: The Rancho Bernardo Study. Diabetes Care 1997;20:645-649.

Goodman-Gruen D, Barrett-Connor E. The epidemiology of insulin-like growth factor-I in elderly men and women: The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-976.

Barrett-Connor E, Goodman-Gruen D. Gender differences in insulin-like growth factor and bone mineral density association in old age: The Rancho Bernardo Study. J Bone Mineral Research 1998;13:13431349.

Barrett-Connor E, Goodman-Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 1999;84:3681-3685.

Barrett-Connor E, Goodman-Gruen D. Endogenous sex hormones and cognitive function in older women. J Am Geriatric Soc 1999;47:1289-1293.

Goodman-Gruen D, Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older adult men and women. Diabetes Care 2000;23:912-918.

Goodman-Gruen D, Barrett-Connor E., Rosen C. Insulin-like growth-factor-I and ischemic heart disease. J Am Geriatric Soc 2000;48:860-1.

Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavones intake and cardiovascular disease risk factors in postmenopausal women. J Nutr. 2001 Apr;131(4)1202-6.

Goodman-Gruen D, Hollenbach K. Prevalence of von Willebrand Disease in women with abnormal uterine bleeding. J Women’s Health. 2001;10(7):677-80.

Lankarani-Fard A, Kritz-Silverstein D, Barrett-Connor E, Goodman-Gruen D. Cumulative duration of breast-feeding influences cortisol levels in postmenopausal women. J Women’s Health & Gender Based Medicine 2001;10(7):681-7.

Broadwin J, Goodman-Gruen D, Slymen D. Ability of fat and fat-free mass percentages to predict functional disability in elderly men and women. J Am Geriatric Soc. 2001;49:1641-5.

Kritz-Silverstein D, Goodman-Gruen D. Usual dietary isoflavone intake, bone mineral density, and bone metabolism in postmenopausal women. J Women’s Health 2002;11:69-78.

Promislow JHE, Goodman-Gruen D, Slymen DJ, Barrett-Connor Elizabeth. Protein Consumption and Bone Mineral Density in the Elderly: The Rancho Bernardo Study. Am J Epidemiol 2002;155:636-44.

Promislow JHE, Goodman-Gruen D, Slymen D, Barrett-Connor E. Retinol Intake and Bone Mineral Density in the Elderly: The Rancho Bernardo Study. J bone Mineral Research 2002;17:1349-1358.

Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake and body composition in postmenopausal women. Menopause. 2003 Sep-Oct;10(5):427-32.

Learman LA, Summitt RL Jr, Varner RE, McNeeley SG, Goodman-Gruen D, Richter HE, Lin F, Showstack J, Ireland CC, Vittinghoff E, Hulley SB, Washington AE; Total or Supracervical Hysterectomy (TOSH) Research Group.A randomized comparison of total or supracervical hysterectomy: surgical complications and clinical outcomes. Obstet Gynecol. 2003 Sep;102(3):453-62.

Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E. Am J Prev Med. 2003 Oct;25(3):226-31. Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med. 2004 Oct;27(3):265.

Kuppermann M, Summitt RL Jr, Varner RE, McNeeley SG, Goodman-Gruen D, Learman LA, Ireland CC, Vittinghoff E, Lin F, Richter HE, Showstack J, Hulley SB, Washington AE; Total or Supracervical Hysterectomy Research Group. Sexual functioning after total compared with supracervical hysterectomy: a randomized trial. Obstet Gynecol. 2005 Jun;105(6):1309-18.

   
Grant Listing:

National Institute of Health/National Institute on Aging, #1 R01AG18339-01. DHEA Replacement in Healthy Older Men & Women. 9/30/00-9/29/05 (Principal Investigator).

Wyeth Research. #0915A3-300-USA. Double Blind Placebo and Historical Control Study of the Safety and Efficacy of Premarin-Trimegesterone for Post-Menopausal Replacement Therapy. 10/99-6/02 (Principal Investigator).

University of California, San Diego, Academic Senate Award, RA835M, Hypertension and Mortality in Women with a History of New onset Hypertension in Pregnancy, 12/15/00-12/31/01 (Principal Investigator).

Protein Technologies Inc. Soy Intervention Program, GTS9301, 5/1/99-4/30/00 (Principal Investigator).

University of California, San Diego, Academic Senate Award, Prevalence of von Willebrand disease in women with abnormal uterine bleeding, (Principal Investigator).

National Institute of Health, AHCPR, Medicine or Surgery (MS?), 1 U01 HS09478-01 (UCSD #96-7007). 9/30/96 - 9/29/01 (Co-Investigator).

National Institute of Health, NHLBI, CVD Risk & Health in Postmenopausal Phytoestrogen Users 1 RO1 HL57790-01 (UCSD #95-6946). 4/1/97 – 3/30/00 (Co-Investigator).

Wyeth-Ayerst Research, A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel, Multicenter Study to Access the Safety and Efficacy of 3½ Day Combinations of 17?-Estradiol/Norethindrone Acetate Transdermal Delivery Systems for Relief of Menopausal Vasomotor Symptoms and Reductions of Endometrial Hyperplasia 00802D1-324-US. (Sub-Investigator)

Wyeth-Ayerst Research, Heart Disease and Estrogen/Progestin Replacement Study (HERS Study) 713B-401-US (UCSD #93-5355). 10/1/92- 12/31/98 (Sub-Investigator).

   
Other Experience Associate Professor
University of California, San Diego 2002—2004

Assistant Professor
University of California, San Diego 1995—2002

Medical Fellow, Department of Family and Preventive Medicine
University of California, San Diego 1993—1995

Prenatal and Family Planning Physician Consultant
Los Angeles County Department of Public Health 1989—1993

Study Physician, NOVO Nordisk Study
University of California, San Diego 1995—2003

Graduate Programs Epidemiology

   
Research Center Genetic Epidemiology Research Institute
   
   
Link to this profile http://www.faculty.uci.edu/profile.cfm?faculty_id=5815
   
Last updated 01/21/2011